Article
The tumor suppressor TERE1 (UBIAD1) prenyltransferase regulates the elevated cholesterol phenotype in castration resistant prostate cancer by controlling a program of ligand dependent SXR target genes.
Oncotarget - 1 Jul 2013
Fredericks William J, Sepulveda Jorge, Lai Priti, Tomaszewski John E, Lin Ming-Fong, McGarvey Terry, Rauscher Frank J, Malkowicz S Bruce
Abstract excerpt
Castrate-Resistant Prostate Cancer (CRPC) is characterized by persistent androgen receptor-driven tumor growth in the apparent absence of systemic androgens. Current evidence suggests that CRPC cells can produce their own androgens from endogenous sterol precursors that act in an intracrine manner to stimulate tumor growth. The mechanisms by which CRPC cells become steroidogenic during tumor progression are not...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
